Combination Therapy of PEG-HM-3 and Methotrexate Retards Adjuvant-Induced Arthritis.

about

The Protective Effect of a Long-Acting and Multi-Target HM-3-Fc Fusion Protein in Rheumatoid Arthritis

P2860

Q58753417-2FA8E186-1611-4345-9205-E90DE5572981

P2860

Combination Therapy of PEG-HM-3 and Methotrexate Retards Adjuvant-Induced Arthritis.

Item

http://www.wikidata.org/entity/Q38650245

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Combination Therapy of PEG-HM-3 and Methotrexate Retards Adjuvant-Induced Arthritis.

@en

type

Item

label

Combination Therapy of PEG-HM-3 and Methotrexate Retards Adjuvant-Induced Arthritis.

@en

prefLabel

Combination Therapy of PEG-HM-3 and Methotrexate Retards Adjuvant-Induced Arthritis.

@en

P1476

Combination Therapy of PEG-HM-3 and Methotrexate Retards Adjuvant-Induced Arthritis.

@en

P2093

Chenyu Lin

http://www.w3.org/2001/XMLSchema#string

Hanmei Xu

http://www.w3.org/2001/XMLSchema#string

Jingchao Hao

http://www.w3.org/2001/XMLSchema#string

Kun Qian

http://www.w3.org/2001/XMLSchema#string

Liting Yu

http://www.w3.org/2001/XMLSchema#string

Qianqian Wu

http://www.w3.org/2001/XMLSchema#string

Sarra Setrerrahmane

http://www.w3.org/2001/XMLSchema#string

Xiaodong Wu

http://www.w3.org/2001/XMLSchema#string

Yueying Hou

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

Alpha 4 integrin antagonists.

Combination treatment with azidothymidine and granulocyte colony-stimulating factor in children with human immunodeficiency virus infection.

Angiogenesis in rheumatoid arthritis.

IL-6 in autoimmune disease and chronic inflammatory proliferative disease.

A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis.

In vivo anti-tumor activity of polypeptide HM-3 modified by different polyethylene glycols (PEG).

Assessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial.

Novel approaches to treating inflammatory bowel disease: targeting alpha-4 integrin.

Notch signaling mediates TNF-α-induced IL-6 production in cultured fibroblast-like synoviocytes from rheumatoid arthritis.

P31

scholarly article

P356

10.3390/IJMS18071538

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28754008

http://www.w3.org/2001/XMLSchema#string

P932

5536026

http://www.w3.org/2001/XMLSchema#string

Combination Therapy of PEG-HM-3 and Methotrexate Retards Adjuvant-Induced Arthritis.

about

P2860

P2860

Combination Therapy of PEG-HM-3 and Methotrexate Retards Adjuvant-Induced Arthritis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P577

P698

P932